Patents by Inventor Daniel Schubart

Daniel Schubart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targets for hepatitis C virus infections
    Publication number: 20050100887
    Abstract: Methods for the detection of compounds useful for prophylaxis and/or treatment of Hepatitis C virus infections and methods for detecting Hepatitis C virus infections in an individual or in cells are disclosed. Mono- or polyclonal antibodies are disclosed effective for the treatment of HCV infections together with methods for treating Hepatitis C virus infections or for the regulation of Hepatitis C virus production and/or replication wherein said antibodies are disclosed. Solid supports useful for detecting Hepatitis C virus infections or for screening compounds useful for prophylaxis and/or treatment of HCV infections are also disclosed.
    Type: Application
    Filed: June 21, 2004
    Publication date: May 12, 2005
    Inventors: Konstadinos Salassidis, Daniel Schubart, Heidrun Gutbrod, Stefan Mueller, Friedrich Kraetzer, Sabine Obert
  • Cellular kinases involved in Cytomegalovirus infection and their inhibition
    Patent number: 6849409
    Abstract: The role of certain cellular kinases active during Human Cytomegalovirus infection is disclosed. These cellular kinases are useful to detect HCMV infection, and can be used to screen for cellular kinase inhibitors. Cellular kinases inhibitors, which effectively downregulate these key cellular components, serve as effective therapeutics against HCMV infection.
    Type: Grant
    Filed: October 16, 2001
    Date of Patent: February 1, 2005
    Assignee: Axxima Pharmaceuticals AG
    Inventors: Daniel Schubart, Peter Habenberger, Matthias Stein-Gerlach, Dorian Bevec
  • Cellular kinases involved in Cytomegalovirus infection and their inhibition
    Publication number: 20030082519
    Abstract: The role of certain cellular kinases active during Human Cytomegalovirus infection is disclosed. These cellular kinases are useful to detect HCMV infection, and can be used to screen for cellular kinase inhibitors. Cellular kinases inhibitors, which effectively downregulate these key cellular components, serve as effective therapeutics against HCMV infection.
    Type: Application
    Filed: October 16, 2001
    Publication date: May 1, 2003
    Inventors: Daniel Schubart, Peter Habenberger, Matthias Stein-Gerlach, Dorian Bevec